SPC Life Sciences IPO Date:SPC Life Sciences IPO Date SPC Life Sciences Limited is a leading Indian pharmaceutical manufacturer of state-of-the-art intermediates for certain key active pharmaceutical ingredients. SPC Life Sciences has a strong track record of desirability and growth. The company’s revenue has grown at a CAGR of over 20% in the past three years & its net profit has grown at a CAGR of over 30%. Date for SPC Life Sciences IPO is not yet reveal, but it may hit by November 2023.
SPC Life Sciences IPO Date
The tentative IPO date for SPC Life Sciences is November 2023. the exact date of the IPO will be make public by the company after the finalisation of the red herring prospectus (RHP). The RHP is a document that contains all the notification about the IPO, including the company’s financial performance, business plans & risk factors. The RHP is typically filed with the Securities & Exchange Board of India (SEBI) a few weeks before the IPO launch. Once the RHP is conclude, SEBI will give its approval for the IPO. After that, the company can make public the exact date of the IPO.
SPC Life Sciences IPO Date Short Information
| Article |
SPC Life Sciences IPO Date |
| Year |
2023 |
| IPO Size |
Approx ₹[.] Crores |
| Website |
Click Here |
SPC Life Sciences IPO Price Band, Lot Size, Allotment, Listing
Price Band
The price band for the SPC Life Sciences IPO is expected to be make public in the red herring prospectus (RHP). The company is anticipate to fix the price band in consultation with its investment bankers & merchant bankers.
Lot Size
The lot size for the SPC Life Sciences IPO is anticipate to be 100 equity shares. This means that investors will have to bid for a minimum of 100 equity shares.
Allotment
The allotment of shares in the SPC Life Sciences IPO will be done on a first-come-first-served basis. lender who apply for the IPO before the closing date will be specified priority in the allotment of shares.
Listing
The shares of SPC Life Sciences are anticipate to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange within a few days of the IPO closing date.
SPC Life Sciences IPO Details
SPC Life Sciences has gotten endorsement from the Protections and Trade Leading body of India (SEBI) to raise ₹300 crore through a first sale of stock (Initial public offering). The Initial public offering will comprise of a new issue of value shares worth ₹300 crore and a Proposal Available to be purchased (OFS) of 89.39 lakh value shares by the organization’s advertiser, Snehal Ravjibhai Patel.
The absolute issue size of the Initial public offering is supposed to be around ₹500 crore. The organization intends to utilize the returns from the Initial public offering to subsidize its development plans, remembering the development of another assembling office for Dahej, Gujarat.
| IPO Open Date |
Not Available |
| IPO Close Date |
Not Available |
| Listing Date |
Not Available |
| Face Value |
₹10 per share |
| Price |
Not Available |
| Lot Size |
Not Available |
| Issue Size |
[●]shares(aggregating up to ₹[●]Cr) |
| Offer For Sale |
8,938,870 shares
(aggregating up to ₹[●] Cr) |
| Fresh Issue |
- shares
- (aggregating up to ₹300 Cr)
|
| Issue Type |
Book Built Issue IPO |
| Listing At |
BSE, NSE |
| QIB Shares Offered |
Not more than 50% of the Offer |
| NII (HNI) Shares Offered |
Not less than 15% of the Offer |
| Retail Shares Offered |
Not less than 35% of the Offer |
| Promoters |
Snehal Ravjibhai Patel |
| Particulars |
6M of FY-23(in cr.) |
6M of FY-22(in cr.) |
FY-22(in cr.) |
FY-21(in cr.) |
FY-20(in cr.) |
CAGR |
| Revenue from Operations |
87.91 |
69.84 |
145.64 |
132.95 |
120.93 |
9.7% |
| Other Income |
0.61 |
0.31 |
0.80 |
3.19 |
0.17 |
|
| Cost of Goods Sold |
55.79 |
39.77 |
86.31 |
83.39 |
76.71 |
6.1% |
| Employee Cost |
7.70 |
7.32 |
14.47 |
12.80 |
12.08 |
|
| Other expenses |
8.72 |
7.39 |
14.83 |
14.22 |
13.71 |
|
| EBITDA |
16.31 |
15.67 |
30.83 |
25.74 |
18.60 |
28.7% |
| EBITDA margin% |
18.56% |
22.44% |
21.17% |
19.36% |
15.38% |
|
| Depreciation |
1.30 |
1.21 |
2.48 |
1.84 |
1.60 |
|
| Interest |
1.26 |
1.30 |
2.47 |
1.69 |
2.83 |
|
| Profit / (loss) before tax |
13.76 |
13.16 |
25.88 |
22.22 |
14.18 |
35.1% |
| Total tax |
3.64 |
3.29 |
6.65 |
5.55 |
3.79 |
|
| Profit / (loss) After-tax |
10.11 |
9.87 |
19.23 |
16.67 |
10.38 |
36.1% |
| Profit / (loss) After-tax margin% |
11.50% |
14.13% |
13.21% |
12.54% |
8.59% |
|
SPC Life Sciences Limited IPO Revenue from Operations
| Segment |
6M of FY-23(in cr.) |
% |
6M of FY-22(in cr.) |
% |
FY-22(in cr.) |
% |
FY-21(in cr.) |
% |
FY-20(in cr.) |
% |
CAGR |
| Sale of products |
87.845 |
99.92% |
69.663 |
99.75% |
145.18 |
99.68% |
132.3 |
99.51% |
119.43 |
98.77% |
10.3% |
| Other Operating Revenues |
0.067 |
0.08% |
0.178 |
0.25% |
0.46 |
0.32% |
0.649 |
0.49% |
1.48 |
1.23% |
-44.3% |
| Total |
87.912 |
100% |
69.841 |
100% |
145.64 |
100% |
132.949 |
100% |
120.92 |
100% |
SPC Life Sciences Limited IPO Major Shareholders
| S.NO. |
Name of the Shareholder |
No. of Shares |
% of pre-Offer shareholding |
| 1. |
Snehal Ravjibhai Patel |
43,880,464 |
98.18% |
| 2. |
Ravjibhai Dudabhai Dudhat |
366,944 |
0.82% |
| 3. |
Sangitaben Ravjibhai Dudhat |
366,944 |
0.82% |
| 4. |
Mili Snehal Patel |
77,000 |
0.17% |
|
Total |
44,691,352 |
99.99% |
Bigg Boss 16 Voting
Instruction to Apply for the SPC Life Sciences IPO
I don’t have specific information about an IPO for a company named “SPC Life Sciences.” The process for applying for an IPO (Initial Public Offering) may vary depending on the company and the stock exchange it plans to list on. To apply for an IPO, you would typically follow these general steps:
Research the IPO
Find information about the company, its business, financials, and the terms of the IPO in the prospectus. The prospectus is a document that provides details about the offering.
Open a Demat and Trading Account
If you don’t already have one, you’ll need to open a Demat (Dematerialized) and trading account with a registered stockbroker. This is where you will hold and trade the shares.
Verify Your KYC (Know Your Customer)
Ensure that your KYC documents are in order. Stockbrokers will require valid identification and address proof.
Choose a Stockbroker
Select a stockbroker through whom you want to apply for the IPO. Some companies may have specific tie-ups with certain brokerage firms for their IPOs.
Place Your Application
Contact your chosen stockbroker or use their online platform to place your IPO application. You’ll typically need to provide information like the number of shares you want to apply for and the bid price.
Payment
Transfer the funds for your IPO application to the designated bank account mentioned in the IPO prospectus. Ensure that you meet the minimum investment criteria, if any.
Monitor Allotment
After the IPO subscription period closes, the company will allot shares to investors. You can check the allotment status through the stock exchange or your stockbroker’s website.
Receive Shares
If you are allot shares, they will be credit to your Demat account. You can then start trading or holding the shares.
SPC Life Sciences Limited IPO Risk Factors
SPC Life Sciences Limited manufacturing processes include the capacity and transportation of different dangerous substances and are likely to working dangers relate with taking care of such unsafe materials like the opportunities for spillages and bursts from holders, blasts and the release or arrival of poisonous or perilous substances, which thusly may cause individual injury, property harm, and ecological tainting. Life Sciences Restricted infers a huge piece of its income from its significant clients and it doesn’t have long haul contracts with these clients. In the event that at least one of such clients decide not to source their necessities from it, its business, monetary condition, and consequences of activities might be unfavorably impacted.
SPC Life Sciences Restricted is dependent upon severe quality prerequisites, customary investigations, and reviews by its clients, and any inability to conform to quality norms might prompt the crossing out of existing and future orders and could adversely affect its business. SPC Life Sciences Restricted infers a critical piece of its income from a couple of items like intermediates for Pentoxifylline and Amiodarone HCL. On the off chance that its items lose favor with the clients or APIs created utilizing its items lose portion of the overall industry or favor with end clients or on the other hand on the off chance that the organization can’t safeguard its licensed innovation in regards to these items or cycles, its business might be unfavorably impacted.
Get Latest News Updates
Ques & Ans Related to SPC Life Sciences IPO Date
What is the price band of GLS IPO?
Glenmark Life Sciences IPO price band is set at ₹695 to ₹720 per share. The minimum lot size for an application is 20 Shares. The minimum amount of investment required by retail investors is ₹14,400.
Who is the director of SPC Life Science?
Current board members & directors are RAVJIBHAI DUDABHAI DUDHAT and SNEHAL RAVJIBHAI PATEL.
What is IPO listing price?
The issue price is the price at which the shares are first sold to investors in an IPO, whereas the listing price is the price at which the shares get list to trade on a stock exchange after the IPO.